Quality of life assessment in the first episode of acute coronary syndrome
Background: Assessment of health-related quality of life (HRQoL) is an important measure of a patient’s recovery after an illness. However, HRQoL among acute coronary syndrome (ACS) survivors has not been extensively studied following cardiac management. Aim: The purpose of this study was to assess the QoL among ACS patients who have undergone percutaneous coronary intervention (PCI).
Methods: This cohort study included 145 consecutive male ACS patients between March 2021 and May 2022. Of these patients, 138 (mean age 54.3 ± 10.7 years) completed the QoL assessment using the short form-12 (SF-12) health survey questionnaire. Seventy (51%) of them presented with ST-segment elevation myocardial infarction, 18 (13%) had non-STEMI, 39 (28%) had evolved MI, and 11 (8%) had unstable angina. Recruited patients’ QoL data were assessed at various time points post-PCI.
Results: At the end of the 12 months of follow-up, major clinical events (MCE) defined as death, sudden death, or re-acute myocardial infarction occurred in 54.9% of patients. Out of 7 MCE, four deaths and three re-AMIs had occurred. SF-12 physical component score was found to be significantly improved when compared to the mental component score, which seems to improve without reaching statistical significance over time. Among event-free ACS patients, we found a significant positive correlation between left ventricular ejection fraction and HRQoL.
Conclusion: Improvement in HRQoL (physical component) was seen among ACS patients post-PCI.
Relevance for patients: QoL assessment outcomes should be considered in clinical settings, practice guidelines, and treatment modality post-PCI to improve QoL in post-ACS survivors.
[1] Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, et al. CREATE Registry Investigators. Treatment and Outcomes of Acute Coronary Syndromes in India (CREATE): A Prospective Analysis of Registry Data. Lancet 2008;371:1435-42.
[2] Bounhoure JP, Farah B, Fajadet J, Marco J. Prognosis After Acute Coronary Syndrome. Lack of Difference According to Sex. Bull Acad Natl Med 2004;188:383-97; discussion 397-9.
[3] Coelho R, Prata J. Quality of life measures in acute coronary syndromes: The Evaluation of predictors in this field of research. In: Preedy VR, Watson RR, editors. Handbook of Disease Burdens and Quality of Life Measures. New York, NY: Springer; 2010. p. 3015-32.
[4] Blankenship JC, Marshall JJ, Pinto DS, Lange RA, Bates ER, Holper EM, et al; Society for Cardiovascular Angiography and Interventions. Effect of Percutaneous Coronary Intervention on Quality of Life: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 2013;81:243-59.
[5] Ware JE Jr., Sherbourne CD. The MOS 36-Item Short-form Health Survey (SF-36). I. Conceptual Framework and Item Selection. Med Care 1992;30:473-83.
[6] Failde I, Medina P, Ramírez C, Arana R. Assessing HealthRelated Quality of Life among Coronary Patients: SF-36 vs SF-12. Public Health 2009;123:615-7.
[7] Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries: Results from the IQOLA Project. J Clin Epidemiol 1998;51:1171-8.
[8] Abrootan S, Yazdankhah S, Payami B, Alasti M. Changes in Heart Rate Variability Parameters After Elective Percutaneous Coronary Intervention. J The Univ Heart Ctr 2015;10:80-4.
[9] Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. 2021 AHA/ACC/ASE/CHEST/ SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021;144:e368-454.
[10] Collet JP, Thiele H, Barbato E, Barthe´le´my O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation. The Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent STSegment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2021;42:1289-367.
[11] U.S. Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: AReport of the Surgeon General. Atlanta: U.S: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
[12] Hackshaw A, Morris JK, Boniface S, Tang JL, Milenković D. Low Cigarette Consumption and Risk of Coronary Heart Disease and Stroke: Meta-Analysis of 141 Cohort Studies in 55 Study Reports. BMJ 2018;363:k5035.
[13] Roerecke M, Rehm J. Chronic Heavy Drinking and Ischaemic Heart Disease: A Systematic Review and MetaAnalysis. Open Heart 2014;1:e000135.
[14] Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland John GF, Coats Andrew JS, et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-200.
[15] Melville MR, Lari MA, Brown N, Young T, Gray D. Quality of Life Assessment using the Short Form 12 Questionnaire is as Reliable and Sensitive as the Short Form 36 in Distinguishing Symptom Severity in Myocardial Infarction Survivors. Heart 2003;89:1445-6.
[16] Ware J Jr., Kosinski M, Keller SD. A 12-Item ShortForm Health Survey (SF-12): Construction of Scales and Preliminary Tests of Reliability and Validity. Med Care 1996;32:220-33.
[17] Seto TB, Taira DA, Berezin R, Chauhan MS, Cutlip DE, Ho KK, et al. Percutaneous Coronary Revascularization in Elderly Patients: Impact on Functional Status and Quality of Life. Ann Intern Med 2000;132:955-8.
[18] Wong MS, Chair SY. Changes in Health-Related Quality of Life Following Percutaneous Coronary Intervention: A Longitudinal Study. Int J Nurs Stud 2007;44:1334-42.
[19] Melberg T, Nordrehaug JE, Nilsen DW. A Comparison of the Health Status After Percutaneous Coronary Intervention at a Hospital with and Without On-Site Cardiac Surgical Backup: A Randomized Trial in Nonemergent Patients. Euro J Cardiovasc Prevent Rehabil 2010;17:235-43.
[20] Anchah L, Hassali MA, Lim MS, Ibrahim MI, Sim KH, Ong TK. Health Related Quality of Life Assessment in Acute Coronary Syndrome Patients: The Effectiveness of Early Phase I Cardiac Rehabilitation. Health Qual Life Outcomes 2017;15:10.
[21] Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, et al. Health Related Quality of Life in Patients with Congestive Heart Failure: Comparison with other Chronic Diseases and Relation to Functional Variables. Heart 2002;87:235-41.
[22] AlRuthia Y, Sales I, Almalag H, Alwhaibi M, Almosabhi L, Albassam AA, et al. The Relationship between Health-Related Quality of Life and Trust in Primary Care Physicians among Patients with Diabetes. Clin Epidemiol 2020;12:143-51.
[23] Mei YX, Wu H, Zhang HY, Hou J, Zhang ZX, Liao W, et al. Health-Related Quality of Life and its Related Factors in Coronary Heart Disease Patients: Results from the Henan Rural Cohort Study. Sci Rep 2021;11:5011.
[24] Reddy YN, Rikhi A, Obokata M, Shah SJ, Lewis GD, AbouEzzedine OF, et al. Quality of Life in Heart Failure with Preserved Ejection Fraction: Importance of Obesity, Functional Capacity, and Physical Inactivity. Eur J Heart Fail 2020;22:1009-18.
[25] Goldenberg M, Danovitch I, IsHak WW. Quality of Life and Smoking. Am J Addict 2014;23:540-62.
[26] Cheng X, Jin C. The Association between Smoking and Health-Related Quality of Life among Chinese Individuals Aged 40 Years and Older: A Cross-Sectional Study. Front. Public Health 2022;10:779789.
[27] Safi S, Sethi NJ, Nielsen EE, Feinberg J, Jakobsen JC, Gluud C. Beta-Blockers for Suspected or Diagnosed Acute Myocardial Infarction. Cochrane Database Syst Rev 2019;12:CD012484.
[28] Dobre D, van Jaarsveld CH, de Jongste MJ, Haaijer Ruskamp FM, Ranchor AV. The Effect of BetaBlocker Therapy on Quality of Life in Heart Failure Patients: A Systematic Review and Meta-Analysis. Pharmacoepidemiol Drug Saf 2007;16:152-9.
[29] Casas R, Castro-Barquero S, Estruch R, Sacanella E. Nutrition and Cardiovascular Health. Int J Mol Sci 2018;19:3988.